Global Non Narcotic Analgesics Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Non Narcotic Analgesics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Analgesics mainly work in the central or peripheral nervous system, selective inhibition and relief of a variety of pain, pain relief and fear of tension and anxiety pain drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Non Narcotic Analgesics Industry Forecast” looks at past sales and reviews total world Non Narcotic Analgesics sales in 2024, providing a comprehensive analysis by region and market sector of projected Non Narcotic Analgesics sales for 2025 through 2031. With Non Narcotic Analgesics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non Narcotic Analgesics industry.
This Insight Report provides a comprehensive analysis of the global Non Narcotic Analgesics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non Narcotic Analgesics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non Narcotic Analgesics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non Narcotic Analgesics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non Narcotic Analgesics.
This report presents a comprehensive overview, market shares, and growth opportunities of Non Narcotic Analgesics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Non Narcotic Analgesics market?
What factors are driving Non Narcotic Analgesics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non Narcotic Analgesics market opportunities vary by end market size?
How does Non Narcotic Analgesics break out by Type, by Application?
The global Non Narcotic Analgesics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Analgesics mainly work in the central or peripheral nervous system, selective inhibition and relief of a variety of pain, pain relief and fear of tension and anxiety pain drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Non Narcotic Analgesics Industry Forecast” looks at past sales and reviews total world Non Narcotic Analgesics sales in 2024, providing a comprehensive analysis by region and market sector of projected Non Narcotic Analgesics sales for 2025 through 2031. With Non Narcotic Analgesics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non Narcotic Analgesics industry.
This Insight Report provides a comprehensive analysis of the global Non Narcotic Analgesics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non Narcotic Analgesics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non Narcotic Analgesics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non Narcotic Analgesics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non Narcotic Analgesics.
This report presents a comprehensive overview, market shares, and growth opportunities of Non Narcotic Analgesics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Non Steroid Antiinflammatory Drug
- Steroid Antiinflammatory Drug
- Hospital
- Medical Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi S.A.
- Novartis AG
- GlaxoSmithKline PLC
- Pfizer
- Reckitt Benckiser
- Endo Pharmaceuticals
What is the 10-year outlook for the global Non Narcotic Analgesics market?
What factors are driving Non Narcotic Analgesics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non Narcotic Analgesics market opportunities vary by end market size?
How does Non Narcotic Analgesics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non Narcotic Analgesics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Non Narcotic Analgesics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Non Narcotic Analgesics by Country/Region, 2020, 2024 & 2031
2.2 Non Narcotic Analgesics Segment by Type
2.2.1 Non Steroid Antiinflammatory Drug
2.2.2 Steroid Antiinflammatory Drug
2.3 Non Narcotic Analgesics Sales by Type
2.3.1 Global Non Narcotic Analgesics Sales Market Share by Type (2020-2025)
2.3.2 Global Non Narcotic Analgesics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Non Narcotic Analgesics Sale Price by Type (2020-2025)
2.4 Non Narcotic Analgesics Segment by Application
2.4.1 Hospital
2.4.2 Medical Center
2.4.3 Others
2.5 Non Narcotic Analgesics Sales by Application
2.5.1 Global Non Narcotic Analgesics Sale Market Share by Application (2020-2025)
2.5.2 Global Non Narcotic Analgesics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Non Narcotic Analgesics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Non Narcotic Analgesics Breakdown Data by Company
3.1.1 Global Non Narcotic Analgesics Annual Sales by Company (2020-2025)
3.1.2 Global Non Narcotic Analgesics Sales Market Share by Company (2020-2025)
3.2 Global Non Narcotic Analgesics Annual Revenue by Company (2020-2025)
3.2.1 Global Non Narcotic Analgesics Revenue by Company (2020-2025)
3.2.2 Global Non Narcotic Analgesics Revenue Market Share by Company (2020-2025)
3.3 Global Non Narcotic Analgesics Sale Price by Company
3.4 Key Manufacturers Non Narcotic Analgesics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non Narcotic Analgesics Product Location Distribution
3.4.2 Players Non Narcotic Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON NARCOTIC ANALGESICS BY GEOGRAPHIC REGION
4.1 World Historic Non Narcotic Analgesics Market Size by Geographic Region (2020-2025)
4.1.1 Global Non Narcotic Analgesics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Non Narcotic Analgesics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Non Narcotic Analgesics Market Size by Country/Region (2020-2025)
4.2.1 Global Non Narcotic Analgesics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Non Narcotic Analgesics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non Narcotic Analgesics Sales Growth
4.4 APAC Non Narcotic Analgesics Sales Growth
4.5 Europe Non Narcotic Analgesics Sales Growth
4.6 Middle East & Africa Non Narcotic Analgesics Sales Growth
5 AMERICAS
5.1 Americas Non Narcotic Analgesics Sales by Country
5.1.1 Americas Non Narcotic Analgesics Sales by Country (2020-2025)
5.1.2 Americas Non Narcotic Analgesics Revenue by Country (2020-2025)
5.2 Americas Non Narcotic Analgesics Sales by Type (2020-2025)
5.3 Americas Non Narcotic Analgesics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non Narcotic Analgesics Sales by Region
6.1.1 APAC Non Narcotic Analgesics Sales by Region (2020-2025)
6.1.2 APAC Non Narcotic Analgesics Revenue by Region (2020-2025)
6.2 APAC Non Narcotic Analgesics Sales by Type (2020-2025)
6.3 APAC Non Narcotic Analgesics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non Narcotic Analgesics by Country
7.1.1 Europe Non Narcotic Analgesics Sales by Country (2020-2025)
7.1.2 Europe Non Narcotic Analgesics Revenue by Country (2020-2025)
7.2 Europe Non Narcotic Analgesics Sales by Type (2020-2025)
7.3 Europe Non Narcotic Analgesics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non Narcotic Analgesics by Country
8.1.1 Middle East & Africa Non Narcotic Analgesics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Non Narcotic Analgesics Revenue by Country (2020-2025)
8.2 Middle East & Africa Non Narcotic Analgesics Sales by Type (2020-2025)
8.3 Middle East & Africa Non Narcotic Analgesics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non Narcotic Analgesics
10.3 Manufacturing Process Analysis of Non Narcotic Analgesics
10.4 Industry Chain Structure of Non Narcotic Analgesics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non Narcotic Analgesics Distributors
11.3 Non Narcotic Analgesics Customer
12 WORLD FORECAST REVIEW FOR NON NARCOTIC ANALGESICS BY GEOGRAPHIC REGION
12.1 Global Non Narcotic Analgesics Market Size Forecast by Region
12.1.1 Global Non Narcotic Analgesics Forecast by Region (2026-2031)
12.1.2 Global Non Narcotic Analgesics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Non Narcotic Analgesics Forecast by Type (2026-2031)
12.7 Global Non Narcotic Analgesics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi S.A.
13.1.1 Sanofi S.A. Company Information
13.1.2 Sanofi S.A. Non Narcotic Analgesics Product Portfolios and Specifications
13.1.3 Sanofi S.A. Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi S.A. Main Business Overview
13.1.5 Sanofi S.A. Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG Non Narcotic Analgesics Product Portfolios and Specifications
13.2.3 Novartis AG Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 GlaxoSmithKline PLC
13.3.1 GlaxoSmithKline PLC Company Information
13.3.2 GlaxoSmithKline PLC Non Narcotic Analgesics Product Portfolios and Specifications
13.3.3 GlaxoSmithKline PLC Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline PLC Main Business Overview
13.3.5 GlaxoSmithKline PLC Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Non Narcotic Analgesics Product Portfolios and Specifications
13.4.3 Pfizer Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Reckitt Benckiser
13.5.1 Reckitt Benckiser Company Information
13.5.2 Reckitt Benckiser Non Narcotic Analgesics Product Portfolios and Specifications
13.5.3 Reckitt Benckiser Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Reckitt Benckiser Main Business Overview
13.5.5 Reckitt Benckiser Latest Developments
13.6 Endo Pharmaceuticals
13.6.1 Endo Pharmaceuticals Company Information
13.6.2 Endo Pharmaceuticals Non Narcotic Analgesics Product Portfolios and Specifications
13.6.3 Endo Pharmaceuticals Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Endo Pharmaceuticals Main Business Overview
13.6.5 Endo Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Non Narcotic Analgesics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Non Narcotic Analgesics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Non Steroid Antiinflammatory Drug
Table 4. Major Players of Steroid Antiinflammatory Drug
Table 5. Global Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 6. Global Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Table 7. Global Non Narcotic Analgesics Revenue byType (2020-2025) & ($ million)
Table 8. Global Non Narcotic Analgesics Revenue Market Share byType (2020-2025)
Table 9. Global Non Narcotic Analgesics Sale Price byType (2020-2025) & (USD/Pcs)
Table 10. Global Non Narcotic Analgesics Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Non Narcotic Analgesics Sale Market Share by Application (2020-2025)
Table 12. Global Non Narcotic Analgesics Revenue by Application (2020-2025) & ($ million)
Table 13. Global Non Narcotic Analgesics Revenue Market Share by Application (2020-2025)
Table 14. Global Non Narcotic Analgesics Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Non Narcotic Analgesics Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Non Narcotic Analgesics Sales Market Share by Company (2020-2025)
Table 17. Global Non Narcotic Analgesics Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Non Narcotic Analgesics Revenue Market Share by Company (2020-2025)
Table 19. Global Non Narcotic Analgesics Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Non Narcotic Analgesics Producing Area Distribution and Sales Area
Table 21. Players Non Narcotic Analgesics Products Offered
Table 22. Non Narcotic Analgesics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Non Narcotic Analgesics Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Non Narcotic Analgesics Sales Market Share Geographic Region (2020-2025)
Table 27. Global Non Narcotic Analgesics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Non Narcotic Analgesics Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Non Narcotic Analgesics Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Non Narcotic Analgesics Sales Market Share by Country/Region (2020-2025)
Table 31. Global Non Narcotic Analgesics Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Non Narcotic Analgesics Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Non Narcotic Analgesics Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Non Narcotic Analgesics Sales Market Share by Country (2020-2025)
Table 35. Americas Non Narcotic Analgesics Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 37. Americas Non Narcotic Analgesics Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Non Narcotic Analgesics Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Non Narcotic Analgesics Sales Market Share by Region (2020-2025)
Table 40. APAC Non Narcotic Analgesics Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 42. APAC Non Narcotic Analgesics Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Non Narcotic Analgesics Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Non Narcotic Analgesics Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 46. Europe Non Narcotic Analgesics Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Non Narcotic Analgesics Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Non Narcotic Analgesics Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Non Narcotic Analgesics Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Non Narcotic Analgesics
Table 52. Key Market Challenges & Risks of Non Narcotic Analgesics
Table 53. Key IndustryTrends of Non Narcotic Analgesics
Table 54. Non Narcotic Analgesics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Non Narcotic Analgesics Distributors List
Table 57. Non Narcotic Analgesics Customer List
Table 58. Global Non Narcotic Analgesics SalesForecast by Region (2026-2031) & (K Pcs)
Table 59. Global Non Narcotic Analgesics RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Non Narcotic Analgesics SalesForecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Non Narcotic Analgesics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Non Narcotic Analgesics SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Non Narcotic Analgesics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Non Narcotic Analgesics SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Non Narcotic Analgesics RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Non Narcotic Analgesics SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Non Narcotic Analgesics RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Non Narcotic Analgesics SalesForecast byType (2026-2031) & (K Pcs)
Table 69. Global Non Narcotic Analgesics RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Non Narcotic Analgesics SalesForecast by Application (2026-2031) & (K Pcs)
Table 71. Global Non Narcotic Analgesics RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi S.A. Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi S.A. Non Narcotic Analgesics Product Portfolios and Specifications
Table 74. Sanofi S.A. Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Sanofi S.A. Main Business
Table 76. Sanofi S.A. Latest Developments
Table 77. Novartis AG Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis AG Non Narcotic Analgesics Product Portfolios and Specifications
Table 79. Novartis AG Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Novartis AG Main Business
Table 81. Novartis AG Latest Developments
Table 82. GlaxoSmithKline PLC Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline PLC Non Narcotic Analgesics Product Portfolios and Specifications
Table 84. GlaxoSmithKline PLC Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. GlaxoSmithKline PLC Main Business
Table 86. GlaxoSmithKline PLC Latest Developments
Table 87. Pfizer Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Non Narcotic Analgesics Product Portfolios and Specifications
Table 89. Pfizer Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Reckitt Benckiser Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 93. Reckitt Benckiser Non Narcotic Analgesics Product Portfolios and Specifications
Table 94. Reckitt Benckiser Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. Reckitt Benckiser Main Business
Table 96. Reckitt Benckiser Latest Developments
Table 97. Endo Pharmaceuticals Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 98. Endo Pharmaceuticals Non Narcotic Analgesics Product Portfolios and Specifications
Table 99. Endo Pharmaceuticals Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. Endo Pharmaceuticals Main Business
Table 101. Endo Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Non Narcotic Analgesics
Figure 2. Non Narcotic Analgesics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non Narcotic Analgesics Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Non Narcotic Analgesics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Non Narcotic Analgesics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Non Narcotic Analgesics Sales Market Share by Country/Region (2024)
Figure 10. Non Narcotic Analgesics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Non Steroid Antiinflammatory Drug
Figure 12. Product Picture of Steroid Antiinflammatory Drug
Figure 13. Global Non Narcotic Analgesics Sales Market Share byType in 2025
Figure 14. Global Non Narcotic Analgesics Revenue Market Share byType (2020-2025)
Figure 15. Non Narcotic Analgesics Consumed in Hospital
Figure 16. Global Non Narcotic Analgesics Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Non Narcotic Analgesics Consumed in Medical Center
Figure 18. Global Non Narcotic Analgesics Market: Medical Center (2020-2025) & (K Pcs)
Figure 19. Non Narcotic Analgesics Consumed in Others
Figure 20. Global Non Narcotic Analgesics Market: Others (2020-2025) & (K Pcs)
Figure 21. Global Non Narcotic Analgesics Sale Market Share by Application (2024)
Figure 22. Global Non Narcotic Analgesics Revenue Market Share by Application in 2025
Figure 23. Non Narcotic Analgesics Sales by Company in 2025 (K Pcs)
Figure 24. Global Non Narcotic Analgesics Sales Market Share by Company in 2025
Figure 25. Non Narcotic Analgesics Revenue by Company in 2025 ($ millions)
Figure 26. Global Non Narcotic Analgesics Revenue Market Share by Company in 2025
Figure 27. Global Non Narcotic Analgesics Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Non Narcotic Analgesics Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Non Narcotic Analgesics Sales 2020-2025 (K Pcs)
Figure 30. Americas Non Narcotic Analgesics Revenue 2020-2025 ($ millions)
Figure 31. APAC Non Narcotic Analgesics Sales 2020-2025 (K Pcs)
Figure 32. APAC Non Narcotic Analgesics Revenue 2020-2025 ($ millions)
Figure 33. Europe Non Narcotic Analgesics Sales 2020-2025 (K Pcs)
Figure 34. Europe Non Narcotic Analgesics Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Non Narcotic Analgesics Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Non Narcotic Analgesics Revenue 2020-2025 ($ millions)
Figure 37. Americas Non Narcotic Analgesics Sales Market Share by Country in 2025
Figure 38. Americas Non Narcotic Analgesics Revenue Market Share by Country (2020-2025)
Figure 39. Americas Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Figure 40. Americas Non Narcotic Analgesics Sales Market Share by Application (2020-2025)
Figure 41. United States Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Non Narcotic Analgesics Sales Market Share by Region in 2025
Figure 46. APAC Non Narcotic Analgesics Revenue Market Share by Region (2020-2025)
Figure 47. APAC Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Figure 48. APAC Non Narcotic Analgesics Sales Market Share by Application (2020-2025)
Figure 49. China Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 53. India Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Non Narcotic Analgesics Sales Market Share by Country in 2025
Figure 57. Europe Non Narcotic Analgesics Revenue Market Share by Country (2020-2025)
Figure 58. Europe Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Figure 59. Europe Non Narcotic Analgesics Sales Market Share by Application (2020-2025)
Figure 60. Germany Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 61.France Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Non Narcotic Analgesics Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Non Narcotic Analgesics Sales Market Share by Application (2020-2025)
Figure 68. Egypt Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Non Narcotic Analgesics in 2025
Figure 74. Manufacturing Process Analysis of Non Narcotic Analgesics
Figure 75. Industry Chain Structure of Non Narcotic Analgesics
Figure 76. Channels of Distribution
Figure 77. Global Non Narcotic Analgesics Sales MarketForecast by Region (2026-2031)
Figure 78. Global Non Narcotic Analgesics Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Non Narcotic Analgesics Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Non Narcotic Analgesics Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Non Narcotic Analgesics Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Non Narcotic Analgesics Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non Narcotic Analgesics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Non Narcotic Analgesics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Non Narcotic Analgesics by Country/Region, 2020, 2024 & 2031
2.2 Non Narcotic Analgesics Segment by Type
2.2.1 Non Steroid Antiinflammatory Drug
2.2.2 Steroid Antiinflammatory Drug
2.3 Non Narcotic Analgesics Sales by Type
2.3.1 Global Non Narcotic Analgesics Sales Market Share by Type (2020-2025)
2.3.2 Global Non Narcotic Analgesics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Non Narcotic Analgesics Sale Price by Type (2020-2025)
2.4 Non Narcotic Analgesics Segment by Application
2.4.1 Hospital
2.4.2 Medical Center
2.4.3 Others
2.5 Non Narcotic Analgesics Sales by Application
2.5.1 Global Non Narcotic Analgesics Sale Market Share by Application (2020-2025)
2.5.2 Global Non Narcotic Analgesics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Non Narcotic Analgesics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Non Narcotic Analgesics Breakdown Data by Company
3.1.1 Global Non Narcotic Analgesics Annual Sales by Company (2020-2025)
3.1.2 Global Non Narcotic Analgesics Sales Market Share by Company (2020-2025)
3.2 Global Non Narcotic Analgesics Annual Revenue by Company (2020-2025)
3.2.1 Global Non Narcotic Analgesics Revenue by Company (2020-2025)
3.2.2 Global Non Narcotic Analgesics Revenue Market Share by Company (2020-2025)
3.3 Global Non Narcotic Analgesics Sale Price by Company
3.4 Key Manufacturers Non Narcotic Analgesics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non Narcotic Analgesics Product Location Distribution
3.4.2 Players Non Narcotic Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON NARCOTIC ANALGESICS BY GEOGRAPHIC REGION
4.1 World Historic Non Narcotic Analgesics Market Size by Geographic Region (2020-2025)
4.1.1 Global Non Narcotic Analgesics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Non Narcotic Analgesics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Non Narcotic Analgesics Market Size by Country/Region (2020-2025)
4.2.1 Global Non Narcotic Analgesics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Non Narcotic Analgesics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non Narcotic Analgesics Sales Growth
4.4 APAC Non Narcotic Analgesics Sales Growth
4.5 Europe Non Narcotic Analgesics Sales Growth
4.6 Middle East & Africa Non Narcotic Analgesics Sales Growth
5 AMERICAS
5.1 Americas Non Narcotic Analgesics Sales by Country
5.1.1 Americas Non Narcotic Analgesics Sales by Country (2020-2025)
5.1.2 Americas Non Narcotic Analgesics Revenue by Country (2020-2025)
5.2 Americas Non Narcotic Analgesics Sales by Type (2020-2025)
5.3 Americas Non Narcotic Analgesics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non Narcotic Analgesics Sales by Region
6.1.1 APAC Non Narcotic Analgesics Sales by Region (2020-2025)
6.1.2 APAC Non Narcotic Analgesics Revenue by Region (2020-2025)
6.2 APAC Non Narcotic Analgesics Sales by Type (2020-2025)
6.3 APAC Non Narcotic Analgesics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non Narcotic Analgesics by Country
7.1.1 Europe Non Narcotic Analgesics Sales by Country (2020-2025)
7.1.2 Europe Non Narcotic Analgesics Revenue by Country (2020-2025)
7.2 Europe Non Narcotic Analgesics Sales by Type (2020-2025)
7.3 Europe Non Narcotic Analgesics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non Narcotic Analgesics by Country
8.1.1 Middle East & Africa Non Narcotic Analgesics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Non Narcotic Analgesics Revenue by Country (2020-2025)
8.2 Middle East & Africa Non Narcotic Analgesics Sales by Type (2020-2025)
8.3 Middle East & Africa Non Narcotic Analgesics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non Narcotic Analgesics
10.3 Manufacturing Process Analysis of Non Narcotic Analgesics
10.4 Industry Chain Structure of Non Narcotic Analgesics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non Narcotic Analgesics Distributors
11.3 Non Narcotic Analgesics Customer
12 WORLD FORECAST REVIEW FOR NON NARCOTIC ANALGESICS BY GEOGRAPHIC REGION
12.1 Global Non Narcotic Analgesics Market Size Forecast by Region
12.1.1 Global Non Narcotic Analgesics Forecast by Region (2026-2031)
12.1.2 Global Non Narcotic Analgesics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Non Narcotic Analgesics Forecast by Type (2026-2031)
12.7 Global Non Narcotic Analgesics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi S.A.
13.1.1 Sanofi S.A. Company Information
13.1.2 Sanofi S.A. Non Narcotic Analgesics Product Portfolios and Specifications
13.1.3 Sanofi S.A. Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi S.A. Main Business Overview
13.1.5 Sanofi S.A. Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG Non Narcotic Analgesics Product Portfolios and Specifications
13.2.3 Novartis AG Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 GlaxoSmithKline PLC
13.3.1 GlaxoSmithKline PLC Company Information
13.3.2 GlaxoSmithKline PLC Non Narcotic Analgesics Product Portfolios and Specifications
13.3.3 GlaxoSmithKline PLC Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline PLC Main Business Overview
13.3.5 GlaxoSmithKline PLC Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Non Narcotic Analgesics Product Portfolios and Specifications
13.4.3 Pfizer Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Reckitt Benckiser
13.5.1 Reckitt Benckiser Company Information
13.5.2 Reckitt Benckiser Non Narcotic Analgesics Product Portfolios and Specifications
13.5.3 Reckitt Benckiser Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Reckitt Benckiser Main Business Overview
13.5.5 Reckitt Benckiser Latest Developments
13.6 Endo Pharmaceuticals
13.6.1 Endo Pharmaceuticals Company Information
13.6.2 Endo Pharmaceuticals Non Narcotic Analgesics Product Portfolios and Specifications
13.6.3 Endo Pharmaceuticals Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Endo Pharmaceuticals Main Business Overview
13.6.5 Endo Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Non Narcotic Analgesics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Non Narcotic Analgesics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Non Steroid Antiinflammatory Drug
Table 4. Major Players of Steroid Antiinflammatory Drug
Table 5. Global Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 6. Global Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Table 7. Global Non Narcotic Analgesics Revenue byType (2020-2025) & ($ million)
Table 8. Global Non Narcotic Analgesics Revenue Market Share byType (2020-2025)
Table 9. Global Non Narcotic Analgesics Sale Price byType (2020-2025) & (USD/Pcs)
Table 10. Global Non Narcotic Analgesics Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Non Narcotic Analgesics Sale Market Share by Application (2020-2025)
Table 12. Global Non Narcotic Analgesics Revenue by Application (2020-2025) & ($ million)
Table 13. Global Non Narcotic Analgesics Revenue Market Share by Application (2020-2025)
Table 14. Global Non Narcotic Analgesics Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Non Narcotic Analgesics Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Non Narcotic Analgesics Sales Market Share by Company (2020-2025)
Table 17. Global Non Narcotic Analgesics Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Non Narcotic Analgesics Revenue Market Share by Company (2020-2025)
Table 19. Global Non Narcotic Analgesics Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Non Narcotic Analgesics Producing Area Distribution and Sales Area
Table 21. Players Non Narcotic Analgesics Products Offered
Table 22. Non Narcotic Analgesics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Non Narcotic Analgesics Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Non Narcotic Analgesics Sales Market Share Geographic Region (2020-2025)
Table 27. Global Non Narcotic Analgesics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Non Narcotic Analgesics Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Non Narcotic Analgesics Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Non Narcotic Analgesics Sales Market Share by Country/Region (2020-2025)
Table 31. Global Non Narcotic Analgesics Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Non Narcotic Analgesics Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Non Narcotic Analgesics Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Non Narcotic Analgesics Sales Market Share by Country (2020-2025)
Table 35. Americas Non Narcotic Analgesics Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 37. Americas Non Narcotic Analgesics Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Non Narcotic Analgesics Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Non Narcotic Analgesics Sales Market Share by Region (2020-2025)
Table 40. APAC Non Narcotic Analgesics Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 42. APAC Non Narcotic Analgesics Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Non Narcotic Analgesics Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Non Narcotic Analgesics Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 46. Europe Non Narcotic Analgesics Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Non Narcotic Analgesics Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Non Narcotic Analgesics Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Non Narcotic Analgesics Sales byType (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Non Narcotic Analgesics Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Non Narcotic Analgesics
Table 52. Key Market Challenges & Risks of Non Narcotic Analgesics
Table 53. Key IndustryTrends of Non Narcotic Analgesics
Table 54. Non Narcotic Analgesics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Non Narcotic Analgesics Distributors List
Table 57. Non Narcotic Analgesics Customer List
Table 58. Global Non Narcotic Analgesics SalesForecast by Region (2026-2031) & (K Pcs)
Table 59. Global Non Narcotic Analgesics RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Non Narcotic Analgesics SalesForecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Non Narcotic Analgesics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Non Narcotic Analgesics SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Non Narcotic Analgesics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Non Narcotic Analgesics SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Non Narcotic Analgesics RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Non Narcotic Analgesics SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Non Narcotic Analgesics RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Non Narcotic Analgesics SalesForecast byType (2026-2031) & (K Pcs)
Table 69. Global Non Narcotic Analgesics RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Non Narcotic Analgesics SalesForecast by Application (2026-2031) & (K Pcs)
Table 71. Global Non Narcotic Analgesics RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi S.A. Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi S.A. Non Narcotic Analgesics Product Portfolios and Specifications
Table 74. Sanofi S.A. Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Sanofi S.A. Main Business
Table 76. Sanofi S.A. Latest Developments
Table 77. Novartis AG Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis AG Non Narcotic Analgesics Product Portfolios and Specifications
Table 79. Novartis AG Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Novartis AG Main Business
Table 81. Novartis AG Latest Developments
Table 82. GlaxoSmithKline PLC Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline PLC Non Narcotic Analgesics Product Portfolios and Specifications
Table 84. GlaxoSmithKline PLC Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. GlaxoSmithKline PLC Main Business
Table 86. GlaxoSmithKline PLC Latest Developments
Table 87. Pfizer Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Non Narcotic Analgesics Product Portfolios and Specifications
Table 89. Pfizer Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Reckitt Benckiser Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 93. Reckitt Benckiser Non Narcotic Analgesics Product Portfolios and Specifications
Table 94. Reckitt Benckiser Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. Reckitt Benckiser Main Business
Table 96. Reckitt Benckiser Latest Developments
Table 97. Endo Pharmaceuticals Basic Information, Non Narcotic Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 98. Endo Pharmaceuticals Non Narcotic Analgesics Product Portfolios and Specifications
Table 99. Endo Pharmaceuticals Non Narcotic Analgesics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. Endo Pharmaceuticals Main Business
Table 101. Endo Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Non Narcotic Analgesics
Figure 2. Non Narcotic Analgesics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non Narcotic Analgesics Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Non Narcotic Analgesics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Non Narcotic Analgesics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Non Narcotic Analgesics Sales Market Share by Country/Region (2024)
Figure 10. Non Narcotic Analgesics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Non Steroid Antiinflammatory Drug
Figure 12. Product Picture of Steroid Antiinflammatory Drug
Figure 13. Global Non Narcotic Analgesics Sales Market Share byType in 2025
Figure 14. Global Non Narcotic Analgesics Revenue Market Share byType (2020-2025)
Figure 15. Non Narcotic Analgesics Consumed in Hospital
Figure 16. Global Non Narcotic Analgesics Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Non Narcotic Analgesics Consumed in Medical Center
Figure 18. Global Non Narcotic Analgesics Market: Medical Center (2020-2025) & (K Pcs)
Figure 19. Non Narcotic Analgesics Consumed in Others
Figure 20. Global Non Narcotic Analgesics Market: Others (2020-2025) & (K Pcs)
Figure 21. Global Non Narcotic Analgesics Sale Market Share by Application (2024)
Figure 22. Global Non Narcotic Analgesics Revenue Market Share by Application in 2025
Figure 23. Non Narcotic Analgesics Sales by Company in 2025 (K Pcs)
Figure 24. Global Non Narcotic Analgesics Sales Market Share by Company in 2025
Figure 25. Non Narcotic Analgesics Revenue by Company in 2025 ($ millions)
Figure 26. Global Non Narcotic Analgesics Revenue Market Share by Company in 2025
Figure 27. Global Non Narcotic Analgesics Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Non Narcotic Analgesics Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Non Narcotic Analgesics Sales 2020-2025 (K Pcs)
Figure 30. Americas Non Narcotic Analgesics Revenue 2020-2025 ($ millions)
Figure 31. APAC Non Narcotic Analgesics Sales 2020-2025 (K Pcs)
Figure 32. APAC Non Narcotic Analgesics Revenue 2020-2025 ($ millions)
Figure 33. Europe Non Narcotic Analgesics Sales 2020-2025 (K Pcs)
Figure 34. Europe Non Narcotic Analgesics Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Non Narcotic Analgesics Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Non Narcotic Analgesics Revenue 2020-2025 ($ millions)
Figure 37. Americas Non Narcotic Analgesics Sales Market Share by Country in 2025
Figure 38. Americas Non Narcotic Analgesics Revenue Market Share by Country (2020-2025)
Figure 39. Americas Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Figure 40. Americas Non Narcotic Analgesics Sales Market Share by Application (2020-2025)
Figure 41. United States Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Non Narcotic Analgesics Sales Market Share by Region in 2025
Figure 46. APAC Non Narcotic Analgesics Revenue Market Share by Region (2020-2025)
Figure 47. APAC Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Figure 48. APAC Non Narcotic Analgesics Sales Market Share by Application (2020-2025)
Figure 49. China Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 53. India Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Non Narcotic Analgesics Sales Market Share by Country in 2025
Figure 57. Europe Non Narcotic Analgesics Revenue Market Share by Country (2020-2025)
Figure 58. Europe Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Figure 59. Europe Non Narcotic Analgesics Sales Market Share by Application (2020-2025)
Figure 60. Germany Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 61.France Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Non Narcotic Analgesics Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Non Narcotic Analgesics Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Non Narcotic Analgesics Sales Market Share by Application (2020-2025)
Figure 68. Egypt Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Non Narcotic Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Non Narcotic Analgesics in 2025
Figure 74. Manufacturing Process Analysis of Non Narcotic Analgesics
Figure 75. Industry Chain Structure of Non Narcotic Analgesics
Figure 76. Channels of Distribution
Figure 77. Global Non Narcotic Analgesics Sales MarketForecast by Region (2026-2031)
Figure 78. Global Non Narcotic Analgesics Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Non Narcotic Analgesics Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Non Narcotic Analgesics Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Non Narcotic Analgesics Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Non Narcotic Analgesics Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Chinese Herbology Market Growth 2024-2030
US$ 3,660.00
February 2024
92 pages
Global Spinal Cord Stimulator (SCS) Device Market Growth 2023-2029
US$ 3,660.00
February 2023
95 pages
Global Dissection Instrument Kit Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
June 2024
94 pages
Global Dental Healing Cap Market Growth 2024-2030
US$ 3,660.00
September 2024
132 pages
Global Metronidazole Injection Market Growth 2023-2029
US$ 3,660.00
March 2023
99 pages
